Immunization Newsbriefs
Link to Main Page
  Back Search the Site Send Your Feedbck  
Immunization Newsbriefs
Read Current Issue Online
Search Newsbriefs Archives
Subscribe to Email Online
Unsubscribe from Email Online
About NNii
Vaccine Information
Health Professionals
Policy Makers
Read Current Newsbriefs

MedImmune Says FluMist Sales Are Far Short of Target
Washington Post; E1
Barbaro, Michael


On Tuesday, MedImmune revealed that its sales of the inhaled influenza vaccine FluMist have been much lower than expected, and that sales for the entire flu season will be less than predicted. The company had expected to sell between 4 million and 5 million doses of the vaccine for the 2003-2004 winter, but it has only sold 400,000 doses so far and does not expect to see a strong uptick in interest as the flu season moves along. MedImmune said that the poor sales could be attributed to the product's high price, its limited availability to patients, and a later commercial introduction than planned.

© Copyright National Network for Immunization Information. The information contained in the National Network for Immunization Information Web site should not be used as a substitute for the medical care and advice of your health care provider. There may be variations in treatment that your health care provider may recommend based on individual facts and circumstances.